List of Studies ( Metabolite:9S-HODE)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST000510 | AN000783 | Assessing metabolic changes to maternal rat liver tissue during and post-pregnancy (part II) | Liver | Mouse | University of Colorado, Denver | Arbitrary units | |
ST002797 | AN004551 | Fetal metabolic adaptations to cardiovascular stress in twin-twin transfusion syndrome | Amniotic fluid | Human | Twin-twin transfusion syndrome | University of Texas Health Science Center at Houston | intensity |
ST000004 | AN000004 | Lipidomics studies on NIDDK / NIST human plasma samples | Blood | Human | LIPID MAPS | nM | |
ST002213 | AN003618 | Metabolic changes in Alzheimer patient-derived induced neurons versus non-demented controls | Fibroblast cells | Human | Alzheimers disease | University of Colorado Denver | peak area |
ST002213 | AN003620 | Metabolic changes in Alzheimer patient-derived induced neurons versus non-demented controls | Fibroblast cells | Human | Alzheimers disease | University of Colorado Denver | peak area |
ST002966 | AN004874 | Metabolomics reveal the pathway of benzylisoquinoline alkaloids in Corydalis yanhusuo bulbs | Plant | Plant | None | Chongqing Academy of Chinese Materia Medica, Chongqing, China | peak area |
ST001218 | AN002031 | Wild type versus TRACK Mice on regular chow and Vitamin A deprived diet | Kidney | Mouse | Cancer | weill cornell medicine | Peak area |
ST002857 | AN004683 | Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I dose-escalation clinical trial - Metabolomics Analysis of Human CSF and Serum | Cerebrospinal fluid | Human | Multiple sclerosis | University of Colorado | Peak area |
ST002858 | AN004688 | Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I dose-escalation clinical trial - Metabolomics Analysis of Human Serum | Blood | Human | Multiple sclerosis | University of Colorado Anschutz Medical Campus | Peak area |
ST000403 | AN000643 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
ST000539 | AN000819 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
ST000422 | AN000668 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000047 | AN000082 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST000047 | AN000083 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |